R. Emsley

First name
Last name
Wright, A. K., Carr, M. J., Kontopantelis, E., Leelarathna, L., Thabit, H., Emsley, R., et al. (2022). Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1113
Wright, A. K., Kontopantelis, E., Emsley, R., Buchan, I., Sattar, N., Rutter, M. K., & Ashcroft, D. M. (2017). Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups. Diabetes Care. http://doi.org/10.2337/dc16-1616
Pate, A., Emsley, R., Ashcroft, D. M., Brown, B., & Van Staa, T. (2019). The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care. BMC Med. http://doi.org/10.1186/s12916-019-1368-8
Wright, A. K., Kontopantelis, E., Emsley, R., Buchan, I. E., Mamas, M. A., Sattar, N., et al. (2019). Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. Circulation. http://doi.org/10.1161/circulationaha.118.039100
Wright, A. K., Suarez-Ortegon, M. F., Read, S. H., Kontopantelis, E., Buchan, I., Emsley, R., et al. (2020). Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings. Circulation. http://doi.org/10.1161/circulationaha.120.046783
Pate, A., Emsley, R., & Van Staa, T. (2020). Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care. Br J Gen Pract. http://doi.org/10.3399/bjgp20X713057
Pate, A., Emsley, R., Sperrin, M., Martin, G. P., & Van Staa, T. (2020). Impact of sample size on the stability of risk scores from clinical prediction models: a case study in cardiovascular disease. Diagn Progn Res. http://doi.org/10.1186/s41512-020-00082-3
Pate, A., Elliott, R. A., Gkountouras, G., Thompson, A., Emsley, R., & Van Staa, T. (2020). The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5023
Wright, A. K., Welsh, P., Gill, J. M. R., Kontopantelis, E., Emsley, R., Buchan, I., et al. (2020). Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia. http://doi.org/10.1007/s00125-020-05169-6
Pate, A., Van Staa, T., & Emsley, R. (2020). An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England. BMC Med Res Methodol. http://doi.org/10.1186/s12874-020-01173-x